u/Mindmed31415

r/shroomstocks r/HelusPharma r/PsychedelicStudies

▲ 57 r/HelusPharma+1 crossposts

How Helus’ new CEO plans to scale its psychedelic drug pipeline

pharmavoice.com

u/Mindmed31415 — 2 days ago

▲ 29 r/shroomstocks

Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights

u/Mindmed31415 — 6 days ago

▲ 10 r/shroomstocks

GH Research Reports Second Quarter 2026 Financial Results and Provides Business Update | GH Research

investor.ghres.com

u/Mindmed31415 — 14 days ago

▲ 14 r/shroomstocks

$ATAI / $LLY merger proxy just dropped (PREM14A)

u/Mindmed31415 — 21 days ago

▲ 13 r/shroomstocks

Thoughts on upcoming HLP003 APPROACH Data

u/Mindmed31415 — 30 days ago

▲ 30 r/shroomstocks

Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions

u/Mindmed31415 — 1 month ago

▲ 25 r/shroomstocks

My short take on COMP006 data:

u/Mindmed31415 — 1 month ago

▲ 40 r/shroomstocks

AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder

ir.ataibeckley.com

u/Mindmed31415 — 2 months ago

▲ 55 r/HelusPharma+1 crossposts

Helus Shares Experience Studying Adjunctive Psychedelic For Major Depressive Disorder

clinicalleader.com

u/Mindmed31415 — 2 months ago

▲ 53 r/shroomstocks

Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026

ir.definiumtx.com

u/Mindmed31415 — 2 months ago

▲ 10 r/PsychedelicStudies+1 crossposts

New Frontiers in Psychedelic Research: Iboga Microdosing with Dr. Burton J. Tabaac & Teresa Yung

u/Mindmed31415 — 2 months ago